Surgery Partners, Inc. (NASDAQ:SGRY) Shares Sold by Zacks Investment Management

Zacks Investment Management decreased its stake in Surgery Partners, Inc. (NASDAQ:SGRY) by 14.1% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 10,095 shares of the company’s stock after selling 1,660 shares during the period. Zacks Investment Management’s holdings in Surgery Partners were worth $325,000 at the end of the most recent reporting period.

Several other large investors have also modified their holdings of the stock. NFJ Investment Group LLC purchased a new stake in Surgery Partners in the 3rd quarter valued at $1,688,000. Janus Henderson Group PLC raised its position in Surgery Partners by 27.5% in the 3rd quarter. Janus Henderson Group PLC now owns 5,497,368 shares of the company’s stock valued at $177,235,000 after purchasing an additional 1,184,450 shares during the last quarter. Harvest Management LLC purchased a new stake in Surgery Partners in the 3rd quarter valued at $455,000. Holocene Advisors LP raised its position in Surgery Partners by 34.4% in the 3rd quarter. Holocene Advisors LP now owns 131,504 shares of the company’s stock valued at $4,240,000 after purchasing an additional 33,680 shares during the last quarter. Finally, Centiva Capital LP raised its position in Surgery Partners by 130.5% during the 3rd quarter. Centiva Capital LP now owns 37,600 shares of the company’s stock worth $1,212,000 after buying an additional 21,290 shares during the last quarter.

Analyst Upgrades and Downgrades

A number of equities analysts have commented on the stock. Cantor Fitzgerald restated an “overweight” rating and set a $43.00 price objective on shares of Surgery Partners in a research report on Friday, October 4th. JPMorgan Chase & Co. cut their price objective on shares of Surgery Partners from $38.00 to $28.00 and set a “neutral” rating for the company in a research report on Tuesday, December 3rd. Benchmark restated a “buy” rating and set a $50.00 price objective on shares of Surgery Partners in a research report on Monday, August 26th. Royal Bank of Canada cut their price objective on shares of Surgery Partners from $49.00 to $35.00 and set an “outperform” rating for the company in a research report on Wednesday, November 20th. Finally, Macquarie restated an “outperform” rating and set a $34.00 price objective on shares of Surgery Partners in a research report on Tuesday, November 19th. One analyst has rated the stock with a sell rating, three have issued a hold rating and six have assigned a buy rating to the stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $37.38.

Surgery Partners Trading Down 3.1 %

SGRY opened at $21.55 on Wednesday. The firm has a market capitalization of $2.74 billion, a P/E ratio of -44.90, a P/E/G ratio of 18.22 and a beta of 2.58. The firm’s 50 day moving average is $27.58 and its 200-day moving average is $28.09. Surgery Partners, Inc. has a 52-week low of $21.10 and a 52-week high of $36.92. The company has a quick ratio of 1.66, a current ratio of 1.80 and a debt-to-equity ratio of 0.99.

Surgery Partners (NASDAQ:SGRY) last released its quarterly earnings results on Tuesday, November 12th. The company reported $0.19 earnings per share for the quarter, missing analysts’ consensus estimates of $0.25 by ($0.06). Surgery Partners had a positive return on equity of 2.85% and a negative net margin of 2.03%. The company had revenue of $770.40 million for the quarter, compared to analyst estimates of $768.99 million. During the same period in the previous year, the business posted $0.15 EPS. The firm’s quarterly revenue was up 14.3% compared to the same quarter last year. Analysts expect that Surgery Partners, Inc. will post 0.73 EPS for the current fiscal year.

Surgery Partners Profile

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.